Atrial natriuretic peptide (ANP) is a biomarker used in heart failure that is closely related to the severity of ventricular remodelling.17, 18 Our preliminary analysis by UCG indicated improved cardiac function following lncRNA MEG3 siRNA treatment. Here, NPPA is linked to heart failure.